Frontlight ResearchEarly access
CompletedNo phase
3D Visualization System in Highly Myopic Cataract Operation
Key facts
- Who runs it
- National Taiwan University Hospital
- Where
- Taiwan1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 40 people enrolled
- Started
- 3 Jul 2024
- Ended
- 31 Dec 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Alcon-NGENUITY®(NG)-system
- Standard cataract operation
- Record updated
- 19 August 2026
Who can take part
- Age
- 20 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- High myopia (axial length of 26 millimeters or more)
- Presence of clinically significant age-related nuclear cataract requiring surgery, assessed using the International Classification System for Cataract (Lens Opacities Classification System III, LOC III), with a graded score indicating nuclear cataract (LOC III NC/NO grade 3-5)
- Participants must be 20 years of age or older
Who cannot take part
- The target eye has undergone vitrectomy surgery
- The target eye has undergone corneal refractive surgery
- Presence of corneal diseases such as corneal dystrophy, corneal trauma, corneal scarring, corneal ulcers, or clinically significant corneal softening that significantly affects the clarity of cataract surgery
- Presence of other non-myopia-related eye diseases significantly affecting the complexity of surgery, such as adhesive uveitis causing adhesions, corneal damage due to trauma or lens dislocation, structural changes and adhesions due to intraocular inflammation, or severe uncorrected strabismus affecting eye alignment
- Complicated cataracts with features such as extreme hardness, complex composition, zonular laxity, lens dislocation, extensive capsular fibrosis, or those falling under the international cataract classification standards LOCIII NO/NC6 or C4-C5 or P4-P5
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study aims to investigate the impact of depth of field differences between the use of the 3D imaging system (NGENUITY® 3D Visualization System, Alcon, TX, USA) and conventional optical microscope in cataract surgery for highly myopic patients on intraoperative parameters and outcomes.
The 2 groups in the trial
- Conventional-binocular-microscope-assisted standard cataract operationExisting treatment, for comparison
In this group, patients undergo standard modern cataract operation during which the surgeon use conventional binocular microscope
Treatment: Standard cataract operation
- Alcon-NGENUITY® (NG)-System-assisted standard cataract operationTreatment being tested
In this group, patients undergo standard modern cataract operation during which the surgeon use the Alcon NGENUITY® (NG) System
Treatment: Alcon-NGENUITY®(NG)-system and Standard cataract operation
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Comparing the Effect of Depth of Focus Difference in High Myopic Patients Receiving Cataract Operations Between 3D Visualization System and Traditional Optical Microscope.
- Record updated
- 19 August 2026